Home > Boards > US Listed > Biotechs > Rapture Therapeutics Inc. (RAPT)

Negative 1,000% plus operating margins. Only Phase 1

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
make it happen Member Profile
Member Level 
Followed By 41
Posts 4,150
Boards Moderated 0
Alias Born 07/14/10
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/13/2021 1:30:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/9/2021 7:36:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/3/2021 4:11:08 PM
RAPT Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire Inc. - 9/3/2021 8:00:00 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 8/30/2021 5:22:03 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/17/2021 7:24:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/12/2021 5:27:47 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/11/2021 8:17:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/11/2021 8:07:47 AM
RAPT Therapeutics Reports Second Quarter 2021 Financial Results GlobeNewswire Inc. - 8/11/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/9/2021 1:28:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/6/2021 1:23:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/26/2021 3:59:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/16/2021 1:01:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/13/2021 2:35:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2021 12:50:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/1/2021 4:32:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/21/2021 5:06:51 PM
RAPT Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchas... GlobeNewswire Inc. - 6/18/2021 12:24:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/17/2021 1:23:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/16/2021 6:53:45 PM
RAPT Therapeutics raises $125M via equity offering Seeking Alpha - 6/16/2021 12:06:18 AM
RAPT Therapeutics Announces Pricing of Public Offering of Common Stock GlobeNewswire Inc. - 6/15/2021 11:07:25 PM
RAPT Therapeutics: Promising Clinical Data Merits a Price Target Hike TipRanks - 6/15/2021 1:26:15 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/14/2021 4:06:34 PM
make it happen Member Level  Monday, 06/14/21 08:30:14 AM
Re: None
Post # of 18 
Negative 1,000% plus operating margins. Only Phase 1 still, A long way to go...

Large negative lose percentages across the board on margins.

Only $0.22 revenue per share

Cash flow will burn all money before end of year.

Profitability
Profit Margin 0.00%
Operating Margin (ttm) -1,064.70%

Management Effectiveness
Return on Assets (ttm) -27.62%
Return on Equity (ttm) -50.34%

Income Statement
Revenue (ttm) 5.33M
Revenue Per Share (ttm) 0.22
Quarterly Revenue Growth (yoy) 30.70%
Gross Profit (ttm) 5.04M
EBITDA -55.53M
Net Income Avi to Common (ttm) -56.27M
Diluted EPS (ttm) -2.29

Balance Sheet
Total Cash (mrq) 98.41M
Total Cash Per Share (mrq) 3.93
Total Debt (mrq) N/A
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 9.21
Book Value Per Share (mrq) 3.69

Cash Flow Statement
Operating Cash Flow (ttm) -45.66M
Levered Free Cash Flow (ttm) -23.3M


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences